February 21, 2018
To address inequities for patients with disabilities, research led by Mayo Clinic has established six essential questions for health care organizations to ask at the point of care. The broad, evidence-based questions are a first step in determining unmet needs of individual patients for whom disabilities are not always easily identified, the researchers say. Mayo […]
Tags: disabilities, disparities research, health disparities research, inequities, Joan Griffin Ph.D., John Knudsen M.D., Mayo Clinic Kern Center for the Science of Health Care Delivery, Megan Morris Ph.D.
February 8, 2018
Mayo Clinic has been partnering with Olmsted Medical Center and several other regional health care providers for more than 50 years in an initiative called the Rochester Epidemiology Project. This collaboration stretches across 27 counties in Minnesota and Wisconsin, allowing researchers to study health and illnesses in the people living in the region or in […]
Tags: Barrett's esophagus, blood clot, Mayo Clinic Kern Center for the Science of Health Care Delivery, nystagmus, ophthalmology, osteoporosis, population health, proton pump inhibitors, REP, Rochester Epidemiology Project, venous thromboembolism
November 6, 2017
Opioid prescriptions from the emergency department (ED) are written for a shorter duration and smaller dose than those written elsewhere, shows new research led by Mayo Clinic. The study, published today in the Annals of Emergency Medicine, also demonstrates that patients who receive an opioid prescription in the ED are less likely to progress to long-term use. This […]
August 2, 2017
Millions of Americans are taking blood-thinning drugs for common medical conditions. Often, they receive prescriptions for more than one when they have multiple chronic diseases or conditions. As Americans age and the number of people on these drugs is expected to steadily increase over the coming decades, researchers are trying to better understand how the […]
Tags: anticoagulant, antiplatelet, blood-thinner, Dr Neena Abraham, gastroenterology, Kern Center, Mayo Clinic Kern Center for the Science of Health Care Delivery, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
June 28, 2017
With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.